Implications of discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance. Pharmacol Rev (2013) 0.96

Initial treatment of hypertension and adherence to therapy in general practice in Italy. Eur J Clin Pharmacol (2005) 0.94

Newer is not always better: all antihypertensive medications do not equally reduce cardiovascular risk. J Gen Intern Med (2012) 0.94

Discontinuation of doxazosin arm of ALLHAT. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack. Lancet (2000) 0.78

First-line antihypertensive therapy. Lancet (2000) 0.77

First-line antihypertensive therapy. Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension. Lancet (2000) 0.75

First-line antihypertensive therapy. Lancet (2000) 0.75

Implications of recent hypertension trials for the generalist physician: whom do we treat, and how? Curr Control Trials Cardiovasc Med (2000) 0.75